Alterola Biotech, Inc. (OTCPK: ABTI)
Health Care · Pharmaceuticals · GB
$—
— today · — 1Y
Alterola Biotech, Inc. (OTCPK: ABTI) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $296.25K and employs 1 people.
trading between 0.00 and 0.01.
Tweenvest scores Alterola Biotech, Inc. across four factors: quality 18/100. Its strongest factor is quality.
ABTI price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $296.25K
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.00
- Dividend yield
- —
- Beta (5Y)
- 64.08
- 52-week high
- $0.01
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 1.48B
- Employees
- 1
- Next earnings
- —
About Alterola Biotech, Inc.
Alterola Biotech, Inc. is a pharmaceutical company dedicated to the research and development of cannabinoid and cannabinoid-like molecules. The firm primarily focuses on pioneering regulated pharmaceutical products for human and animal health, as well as regulated food items. Key activities also include the production of active pharmaceutical ingredients (APIs) and food-grade components. Furthermore, the company emphasizes drug formulation and advanced delivery systems to improve bioavailability, solubility, and overall stability. It operates out of Birkenhead, United Kingdom.
- Listed since
- May 5, 2010
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,257.75 | +0.19% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $271.37 | +0.42% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $153.56 | +0.66% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.90 | -1.25% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.48 | -0.76% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.14 | +0.25% |
Figures last refreshed Aug 18, 2026.